ConductScience.org, home

Paper326381

Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.

Fisher B and 19 others. Cancer, 1977. Cited by 342 papers, by iCite.

Cite this record

ConductScience Library. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Papers, record 326381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326381

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
342
iCite
Relative citation ratio, by iCite
10.3
iCite
Revised in PubMed
2019-06-19
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher BB
2Montague EE
3Redmond CC
4Barton BB
5Borland DD
6Fisher ERE R
7Deutsch MM
8Schwarz GG
9Margolese RR
10Donegan WW
11Volk HH
12Konvolinka CC
13Gardner BB
14Cohn I JrI
15Lesnick GG
16Cruz ABA B
17Lawrence WW
18Nealon TT
19Butcher HH
20Lawton RR

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Clinical Trials as Topic
Female
Humans
Lymph Node Excision
Mastectomy
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Prospective Studies

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05865964Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of InnovationsBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 342 citations.

PMIDTitleJournalYearIn PapersSource
42608978Association between sentinel lymph node number and prognosis in cT1-2N0M0 early breast cancer patients with negative sentinel lymph nodes: a single‑center retrospective cohort study.Ann Med2026https://conductscience.org/library/papers/42608978PubMed
42488634Survival outcomes of axillary de-escalation following neoadjuvant chemo-immunotherapy in clinically node-positive triple-negative breast cancer: a national cancer database study.Front Immunol2026https://conductscience.org/library/papers/42488634PubMed
42299294Essentials for optimizing outcomes in oncoplastic breast reconstruction.Gland Surg2026https://conductscience.org/library/papers/42299294PubMed
42147263Omission of Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: Expanding Evidence in Clinically Node-Negative and Neoadjuvant Therapy Responders.World J Oncol2026https://conductscience.org/library/papers/42147263PubMed
42136760De-Escalation of Axillary Surgery: A Review of Choosing Wisely Guideline Evidence.World J Oncol2026https://conductscience.org/library/papers/42136760PubMed
41215861The chronologic history of post-mastectomy breast reconstructive surgery in the United Kingdom from 1975 to 2025.Gland Surg2025https://conductscience.org/library/papers/41215861PubMed
40976831De-escalating axillary surgery in node-positive early breast cancer patients undergoing primary surgery: current evidence and recommendations.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/40976831PubMed
40756954Omitting sentinel lymph node biopsy in early breast cancer: too bold or the future?Transl Breast Cancer Res2025https://conductscience.org/library/papers/40756954PubMed
40149336Impact of Axillary Burden on Survival: A Comparative Study of Invasive Lobular Carcinoma and Invasive Ductal Carcinoma in Early-Stage Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40149336PubMed
40103401Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer.BJS Open2025https://conductscience.org/library/papers/40103401PubMed
39941099The Role of Molecular Profiling in De-Escalation of Toxic Therapy in Breast Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/39941099PubMed
39748531Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey.Radiat Oncol J2024https://conductscience.org/library/papers/39748531PubMed
39717616The History of Breast Cancer Early Detection: 1865 - 2020.Breast Cancer (Dove Med Press)2024https://conductscience.org/library/papers/39717616PubMed
39610919Incidental discovery of invasive lobular carcinoma and anaplastic large cell lymphoma during sentinel lymph node biopsy: a case report.Front Oncol2024https://conductscience.org/library/papers/39610919PubMed
39031783Who still needs surgical staging of the axilla for invasive breast cancer?J Surg Oncol2025https://conductscience.org/library/papers/39031783PubMed
38534954Personalized Radiation Therapy for Breast Cancer.Curr Oncol2024https://conductscience.org/library/papers/38534954PubMed
38130814Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy.Breast Care (Basel)2023https://conductscience.org/library/papers/38130814PubMed
37922004Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future.Radiol Med2024https://conductscience.org/library/papers/37922004PubMed
37324309Who Needs Level III Lymph Node Dissection in Carcinoma Breast-Study from a Tertiary Care Center.Indian J Surg Oncol2023https://conductscience.org/library/papers/37324309PubMed
36975448Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review.Curr Oncol2023https://conductscience.org/library/papers/36975448PubMed

See all 84 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/326381

GET https://conductscience.org/api/papers/v1/326381/cited_by?page=2